vimarsana.com

Latest Breaking News On - Erica barnell - Page 2 : vimarsana.com

Exact Sciences sues maker of rival colon cancer test

Madison-based Exact Sciences says St. Louis-based Geneoscopy s new ColoSense test violates a patent on collecting and processing stool samples.

United statesErica barnellDrug administrationTrademark officeExact sciencesExact scienceExact science cologuard

Exact Sciences sues maker of rival colon cancer test

Madison-based Exact Sciences says St. Louis-based Geneoscopy s new ColoSense test violates a patent on collecting and processing stool samples.

United statesErica barnellTrademark officeDrug administrationExact sciencesExact scienceExact science cologuard

Home stool test detects bowel cancer with over 90 per cent accuracy

A screening test for bowel cancer that looks for RNA in stools can be done at home and is almost as good at detecting the condition as gold-standard colonoscopies

Erica barnellDrug administrationBowel cancer

Geneoscopy to Present and Exhibit at American College of Gastroenterology 2023 Annual Meeting

ST. LOUIS, October 05, 2023 Geneoscopy will showcase its noninvasive RNA-based technology platform designed to improve diagnostic tools for gastrointestinal health.

United statesBritish columbiaErica barnellAndrew barnellDrug administration breakthrough deviceAmerican college of gastroenterologyGeneoscopy incShowcase its noninvasiveTechnology platform designedImprove diagnostic toolsAmerican collegeScientific meetingPlenary sessionGeneral endoscopyPractice managementColorectal cancer

Geneoscopy Submits PMA Application to FDA for Stool-Based Colorectal Cancer Screening Test

The application is supported by data from the company's prospective trial, demonstrating 94 percent sensitivity for CRC in an average-risk cohort.

United statesErica barnellAndrew barnellDrug administration

vimarsana © 2020. All Rights Reserved.